BioSpace News Archive

Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that its Applied DNA Clinical Laboratories, LLC (ADCL) subsidiary is experiencing growing demand for its safeCircle™ pooled COVID-19 surveillance testing program that is being primarily driven by New York State (the “State”) schools moving to comply with the State’s Winter COVID-19 Plan

DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, today announced the acquisition of LiteCure®, the market leader in therapeutic laser technology for human and animal health.

Spinal Elements, a spine technology company, today announced the first procedure with its Sapphire X Anterior Cervical Fixation System.

The global rare disease gene therapy is expected to witness a significant growth in the forecast period, 2020-2030 on account of the increasing cases of genetic diseases worldwide.

The rising threat of immunological and autoimmune diseases across the globe and the escalating awareness about ways to overcome these diseases may help the immunology drug market may gain substantial growth across the assessment period of 2020-2030.

Blood-Based AlzoSure Assay Has Potential to Transform Management of Alzheimer’s Disease by Identifying Patients Early in the Disease Process

The shareholders of Medivir AB, reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the extraordinary general meeting on Wednesday 13 January 2021.

The San Diego office of American Specialty Health Incorporated has been named among San Diego’s “Top Workplaces” in the 8th annual Top Workplaces awards sponsored by the San Diego Union Tribune and Philadelphia-based Energage.

Vizient, Inc. called for the Centers for Medicare and Medicaid Services to delay the start of the recently finalized Most Favored Nation Model for certain physician-administered drugs.

The board of directors of Pfizer Inc. (NYSE:PFE) declared a 39-cent first-quarter 2021 dividend on the company’s common stock, payable March 5, 2021, to holders of the Common Stock of record at the close of business on January 29, 2021.